Hairy Cell Leukemia

Common Name(s)

Hairy Cell Leukemia

Hairy cell leukemia is a rare, slow-growing cancer of the blood in which the bone marrow makes too many B cells (lymphocytes), a type of white blood cell that fights infection. The condition is named after these excess B cells which look 'hairy' under a microscope. As the number of leukemia cells increases, fewer healthy white blood cells, red blood cells and platelets are produced. The underlying cause of this condition is unknown. While there is no cure, treatment can lead to remission which can last for years.   
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hairy Cell Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hairy Cell Leukemia" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hairy Cell Leukemia" returned 286 free, full-text research articles on human participants. First 3 results:

[Detection of BRAF V600E mutation in hairy cell leukemia by high- resolution melting analysis].
 

Author(s): Yanru Zhang, Huimin Liu, Junyuan Qi, Wei Liu, Lugui Qiu

Journal: Zhonghua Xue Ye Xue Za Zhi. 2014 Mar;35(3):207-9.

 

To explore the feasibility and diagnostic implication of BRAF V600E mutation identified by high-resolution melting (HRM) assay in patients with hairy cell leukemia (HCL).

Last Updated: 26 Mar 2014

Go To URL
Variant B cell receptor isotype functions differ in hairy cell leukemia with mutated BRAF and IGHV genes.
 

Author(s): Nicola J Weston-Bell, Francesco Forconi, Hanneke C Kluin-Nelemans, Surinder S Sahota

Journal:

 

A functional B-cell receptor (BCR) is critical for survival of normal B-cells, but whether it plays a comparable role in B-cell malignancy is as yet not fully delineated. Typical Hairy Cell Leukemia (HCL) is a rare B-cell tumor, and unique in expressing multiple surface immunoglobulin ...

Last Updated: 5 Feb 2014

Go To URL
Efficacy of vemurafenib in hairy-cell leukemia.
 

Author(s): Jesvin Samuel, Salvador Macip, Martin J S Dyer

Journal: N. Engl. J. Med.. 2014 Jan;370(3):286-8.

 

Last Updated: 16 Jan 2014

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hairy Cell Leukemia" returned 12 free, full-text review articles on human participants. First 3 results:

[Recurrent somatic mutation in hairy cell leukemia].
 

Author(s): Eszter Sári, Zsolt Nagy, Judit Demeter

Journal: Orv Hetil. 2013 Jan;154(4):123-7.

 

Hairy cell leukemia is a mature B-cell non-Hogkin lymphoma characterized by unique clinical, morphological and immunhistochemical features. Patients with hairy cell leukemia usually present with splenomegaly, progressive pancytopenia and a relative indolent clinical course. The diagnosis ...

Last Updated: 21 Jan 2013

Go To URL
Immunoconjugates and new molecular targets in hairy cell leukemia.
 

Author(s): Robert J Kreitman

Journal: Hematology Am Soc Hematol Educ Program. 2012 ;2012():660-6.

 

Hairy cell leukemia (HCL) is a B-cell malignancy that in its classic form is exquisitely sensitive to single-agent purine analog therapy, but that is associated in many patients with late relapse and eventual purine analog resistance. Minimal residual disease, which is present in ...

Last Updated: 12 Dec 2012

Go To URL
The microenvironment in hairy cell leukemia: pathways and potential therapeutic targets.
 

Author(s): Jan A Burger, Mariela Sivina, Farhad Ravandi

Journal: Leuk. Lymphoma. 2011 Jun;52 Suppl 2():94-8.

 

Hairy cell leukemia (HCL) cells accumulate and proliferate in the spleen and the bone marrow. In these tissue compartments, HCL cells interact with accessory cells, matrix proteins, and various cyctokines, collectively referred to as the 'microenvironment.' Surface receptors expressed ...

Last Updated: 23 May 2011

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in Genetics Home Reference.

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Ibrutinib in Treating Patients With Relapsed Hairy Cell Leukemia
 

Status: Recruiting

Condition Summary: Progressive Hairy Cell Leukemia Initial Treatment; Refractory Hairy Cell Leukemia; Untreated Hairy Cell Leukemia

 

Last Updated: 18 Feb 2015

Go to URL
Therapy Optimisation for the Treatment of Hairy Cell Leukemia
 

Status: Recruiting

Condition Summary: Hairy Cell Leukemia

 

Last Updated: 2 May 2014

Go to URL
Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia
 

Status: Recruiting

Condition Summary: Hairy Cell Leukemia

 

Last Updated: 10 Dec 2014

Go to URL